Biogen Says It's Under Investigation by Milan Prosecutor
This article is for subscribers only.
Biogen Inc. said its interactions with health-care providers in Italy are under investigation by a prosecutor in Milan.
The drugmaker learned of the investigation this month and is cooperating with the Italian government, according to a securities filing Tuesday. The company didn’t provide further details about the probe. Biogen spokesman Matt Fearer confirmed by email that the company’s Milan office was visited by officials acting on behalf of the prosecution Office of that city, adding it would be inappropriate to comment further.